Sulfonylureas: Scoring beyond START STUDY
Open Access
- 1 January 2017
- journal article
- letter
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 21 (6) , 928-929
Abstract
Indian J Endocr Metab, Official publication of Endocrine Society of India,IndiaKeywords
This publication has 8 references indexed in Scilit:
- Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care DatabaseDiabetes Technology & Therapeutics, 2016
- Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year dataDiabetes, Obesity and Metabolism, 2015
- Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysisInternational Journal Of Clinical Practice, 2015
- Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementIndian Journal of Endocrinology and Metabolism, 2015
- Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trialsBMJ Open, 2014
- Cardiovascular safety of combination therapies with incretin‐based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus – a retrospective nationwide studyDiabetes, Obesity and Metabolism, 2014
- Membrane Potential-Dependent Inactivation of Voltage-Gated Ion Channels in α-Cells Inhibits Glucagon Secretion From Human IsletsDiabetes, 2010
- Mechanism by which metformin reduces glucose production in type 2 diabetes.Diabetes, 2000